A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
Rolf Postina(Johannes Gutenberg University Mainz), Falk Fahrenholz(Johannes Gutenberg University Mainz), Antoine Dequenne(University of Mons), Claudia Prinzen(Johannes Gutenberg University Mainz), Emile Godaux(University of Mons), Kristina Endres(Johannes Gutenberg University Mainz), Ilse Dewachter(Hasselt University), Pascaline Flamez(University of Mons), Ulrich Schmitt(Johannes Gutenberg University Mainz), Anja Schroeder(Johannes Gutenberg University Mainz), Fred Van Leuven(KU Leuven), Manfred Blessing(University of Applied Sciences Mainz), Elżbieta Kojro(Johannes Gutenberg University Mainz), J. Bohl, Christoph Hiemke(Johannes Gutenberg University Mainz)
Cited by 54
Related Papers
Hallmarks of neurodegenerative diseases
|Cell|2023|1.6k
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
|Pharmacopsychiatry|2017|1.4k
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
|JAMA Neurology|2019|876
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622